allergan aesthetics account

JUVDERM VOLLURE XC injectable gel is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) in adults over the age of 21. Pre-existing Conditions at the Injection Site. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. Allergan, Merz and Galderma: Product and Ordering - MedAesthetics Director, National Accounts at Allergan Lafayette, Louisiana . Allergan Aesthetics | BOTOX (Botulinum toxin, Type A) Do not inject into blood vessels. For more information, please see theInstructions for Use (IFU)andUser Manualfor REVOLVE Systemavailable atwww.allergan.com/REVOLVEIFUor call 1.800.678.1605. Consult the CoolSculpting System User Manual for a complete list of Contraindications, Warnings, Precautions, and potential side effects. Serious and/or immediate hypersensitivity reactions have been reported. Explore A career at AbbVie As one company, our ~50,000 employees around the world focus on discovering and . Warnings and Precautions:In patients usingLUMIGAN(bimatoprost ophthalmic solution) or other prostaglandin analogs for the treatment of elevated intraocular pressure (IOP), the concomitant use ofLATISSEmay interfere with the desired reduction in IOP. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Patients with a diagnosis of depression, or other mental health disorders, should wait until resolution or stabilization of these conditions prior to undergoing breast implantation surgery. For JUVDERM VOLLURE XC, JUVDERM Ultra Plus XC, or JUVDERM Ultra XC, most resolved within 14 days; and for JUVDERM VOLBELLA XC, most resolved within 30 days. The volume of blood loss and endogenous body fluid loss may adversely affect intra and/or postoperative hemodynamic stability and patient safety. See our locations. AbbVie & Allergan - Careers | AbbVie When we developed the Allergan Practice Consulting (APC) program our goal was to create unique solutions to address our customer's unmet practice management needs. Pfizer COVID-19 vaccine EU CMA. Natrelle Breast Implants are indicated for women for the following: CONTRAINDICATIONS Injections that are too superficial into the dermis may result in skin ulceration and necrosis. 2022 AbbVie. Indications and Important Safety Information. 1 The future of aesthetics is here. Earn & Redeem Allergan Brilliant Distinctions coupons for more . JUVDERM Ultra XC injectable gel is also indicated for injection into the lips and perioral area for lip augmentation in adults over the age of 21. These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products. Treatment results may vary. Consider withholding subsequent treatments until resolution. How will the acquisition of Allergan impact searching and applying for careers? As with any medical procedure, a consultation should be done by a licensed healthcare professional to determine if the patient is a candidate for treatment. For more information on LATISSE, please see the full Prescribing Information. Onset and duration may vary among individuals and may persist. Allergan Direct provides you with the convenience to manage your account online. Lack of Interchangeability Between Botulinum Toxin Products. Avoid use of KYBELLA in patients with current or prior history of dysphagia as treatment may exacerbate the condition. The most commonly reported side effects for JUVDERM injectable gels were redness, swelling, pain, tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. ApplyLATISSEonly to the skin of the upper eyelid margin at the base of the eyelashes. CoolTone should be used with caution in patients with Graves disease, active bleeding disorders, or seizure disorders. This product contains albumin, a derivative of human blood. Contact the Dermatology Office of Dr. Ellen Turner for advice about facial aesthetic treatments and choosing the right provider. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOXCosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method. We create the products and technologies that drive the advancement of aesthetic medicine. Terms of Use and Online Service Agreement. The most frequently reported adverse reactions following injection of BOTOXCosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%), and eyelid ptosis (2%). For more information, please see theInstructions for Use (IFU)andUser Manualfor REVOLVE Systemavailable atwww.allergan.com/REVOLVEIFUor call 1.800.678.1605. To report an adverse reaction, please call Allergan at 1.800.367.5737. These products have not been approved by the FDA, and the statements on these pages have not been evaluated by the FDA. Allergan New Account Request Please see BOTOX Cosmetic fullPrescribing Informationincluding Boxed Warning andMedication Guide. The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Our goal is to consistently provide our customers with innovation, education, exceptional service, and a . FAQ | Allergan To report an adverse reaction, please call Allergan at 1.800.367.5737. This device should be used with extreme caution in patients with chronic medical conditions such as diabetes, heart, lung, or circulatory system disease or obesity. Actual patient. The potency units of BOTOXCosmetic are specific to the preparation and assay method utilized. ADVERSE REACTIONS Our world-class team develops, manufactures and commercializes innovative branded pharmaceuticals, devices, biologic and tissue products for patients around the world. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care and more. Direct to Physician Account Setup. Dermatologist Dr. Ellen Turner Receives Allergan Medical You are leaving the Allergan Aesthetics website and connecting to a site that is corporate. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing . Ensure that persons with pacemakers are not present in vicinity of the device during treatment. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products. This device will not, in and of itself, produce significant weight reduction. Argentina Australia Austria Brazil Canada Chile China France Germany India Italy Japan Mexico Netherlands Portugal Spain Switzerland Taiwan Thailand Turkey UK US Privacy Notices. It also helps deliver content-specific information to you and tracks how sections of websites are used. Direct Access 24/7 Allergan Direct provides you with the convenience to manage your account online. JUVDERM VOLUMA XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face and for augmentation of the chin region to improve the chin profile in adults over the age of 21. Marginal Mandibular Nerve Injury Manager salaries - 30 salaries reported. Allergan Aesthetics has an overall rating of 3.3 out of 5, based on over 55 reviews left anonymously by employees. Allergan is now part of AbbVie. For JUVDERM VOLUMA XC, most resolved within 2 to 4 weeks. We are dedicated to promoting excellence in clinical practice and improving patient outcomes. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur, Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled, To minimize the risks of potential complications, this product should only be used by healthcare professionals with appropriate experience and training on facial anatomy and product use in indicated area(s), vasculature, safe injection techniques, and identification and management of potential adverse events, including intravascular complications, The potential risks of soft-tissue injections should be discussed with patients prior to treatment to ensure they are aware of signs and symptoms of complications, The safety and effectiveness for the treatment of anatomic regions other than indicated areas for each product have not been established in controlled clinical studies, The safety for use of these products during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied, The safety for use of JUVDERM VOLUMA XC has been established in patients between 35 and 65 years of age for cheek augmentation and in patients between 22 and 80 years of age for chin augmentation, The safety for use of JUVDERM Ultra Plus XC and JUVDERM Ultra XC in patients under 18 years, and JUVDERM VOLLURE XC and JUVDERM VOLBELLA XC in patients under 22 years, has not been established, As with all transcutaneous procedures, dermal filler implantation carries a risk of infection, Dermal fillers should be used with caution in patients on immunosuppressive therapy, Patients taking medications that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites, Patients who experience skin injury near the site of implantation may be at a higher risk for adverse events, If laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment, or before skin has healed from a procedure prior to treatment, there is a possible risk of eliciting an inflammatory reaction at the injection site, The safety for use of JUVDERM VOLUMA XC injectable gel in patients with very thin skin in the mid-face has not been established, The safety of JUVDERM VOLUMA XC with cannula for cheek augmentation has not been established in patients with Fitzpatrick Skin Types V and VI, JUVDERM VOLUMA XC was not evaluated in subjects with significant skin laxity of the chin, neck, or jaw in the chin augmentation study, The effect of JUVDERM VOLUMA XC injection into the chin on facial hair growth has not been studied, Patients may experience late-onset adverse events with use of these dermal fillers, and late-onset nodules with use of JUVDERM VOLUMA XC, Based on preclinical studies, patients should be limited to 20 mL of any JUVDERM injectable gel per 60 kg (130 lbs) body mass per year. Other systemic conditions have been reported with breast implants. Grants and Donations | Allergan Aesthetics Customer Experience Team New accounts, payment inquiries, and more 1-800-377-7790 . Ask your patient about any medical conditions including recent surgery, pre-existing hernia, and any known sensitivities or allergies. Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Results of this procedure may or may not be permanent. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined. Allergan Aesthetics is making available the most up-to-date information possible about the COVID-19 vaccine and dermal filler use for practitioners to review based on published information. Treatment applications that deviate from the guidelines are not recommended. Average salaries for Allergan Aesthetics Legal Director: [salary]. This product contains albumin, a derivative of human blood. Products in the JUVDERM Collection are available only by a licensed physician or properly licensed practitioner. Your browser currently is not set to accept Cookies. CoolTone is also contraindicated in placing the active applicator over menstruating uterus, over areas of the skin that lack normal sensation, and in patients with fever, malignant tumor, hemorrhagic conditions, epilepsy, recent surgical procedure, pulmonary insufficiency, or pregnancy. Patients using prostaglandin analogs includingLUMIGANfor IOP reduction should only useLATISSEafter consulting with their physician and should be monitored for changes to their intraocular pressure. Explore the vast array of educational resources available to you as part of the AMI. All The goal of this role is the development of sales of Allergan products at the assigned group of customer accounts through building and maintaining effective long-term relationship . For JUVDERM VOLBELLA XC, dryness was also reported. Excessive neuromuscular weakness may be exacerbated byadministration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin. JUVDERM Ultra Plus XC and JUVDERM Ultra XC injectable gels are indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds). Treatment with BOTOXand other botulinum toxin products can result in swallowing or breathing difficulties. If you would like to access our global sites please click Yes. Please turn it on or check if you have another program set to block cookies. PRECAUTIONS Canada - Allergan - Allergan There are no data on the presence of BOTOXCosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production. For JUVDERM VOLUMA XC, most resolved within 2 to 4 weeks. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Do not use the product if sterile packaging is damaged. See details. Pre-existing Conditions at the Injection Site. For patients/caregivers, please consult with your physician or contact ourMedical Information Department. Press Release - Allergan Aesthetics To avoid the potential of tissue damage, KYBELLA should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles. Log In Email Password Remember me Forgot password Log In If you have never purchased products from Allergan before, please click here to learn more and register . Contact your practice administrator or Allergan Customer Service. Allergan Contact Information - Contact | AbbVie Healthcare Providers - Allergan The volume of blood loss and endogenous body fluid loss may adversely affect intra and/or postoperative hemodynamic stability and patient safety. Allergan Aesthetics Deliver sales performance, brand KPIs, financial targets, marketing objectives, etc. Commissioned by Allergan Aesthetics and independently developed by specialist trend forecasting agency Wunderman Thompson Intelligence, the report aims to help the industry understand the developments driving today's aesthetics market, and to highlight the key trends that may shape it in the years ahead. For physicians in need of a sales rep and/or samples, please call: 1 800-678-1605. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, unusual pain during or shortly after the procedure. Furthermore, you can find the "Troubleshooting Login Issues" section which can answer your unresolved problems and equip you . In several of the cases, patients had pre-existing dysphagia or other significant disabilities. UAE Medical Aesthetic Devices Markets Report 2022-2027 Featuring Allergan, Alma Lasers, Johnson & Johnson, Alcon, Galderma, Hologic, Syneron Medical, & Bausch Health Companies About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Pfizer COVID-19 vaccine UK EUA KYBELLA is contraindicated in the presence of infection at the injection sites. Allergan is now part of AbbVie. Cases of injection site alopecia have been reported with administration of KYBELLA. Search for Careers Working at Allergan A dynamic organization that offers exciting and unique opportunities at all levels. Cases of injection site ulceration and necrosis have been reported with administration of KYBELLA. Postmarketing reports indicate that the effects of BOTOX Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. Please discuss any history of mental health disorders prior to surgery. WARNINGS Please visitJuvedermDFU.comfor more information. Provide your account email to receive an email to reset your password. Allergan Aesthetics | 28,836 followers on LinkedIn. Allergan Aesthetics | An AbbVie Company Increased iris pigmentation has occurred when bimatoprost solution was administered. LATISSEshould be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema. Allergan is a bold, global pharmaceutical company. Adverse Reactions:The most frequently reported adverse reactions were eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and periorbital erythema. learn more and register when working with non-allergan customers who are considering aesthetics, duties include: assessment of customer needs, gathering of basic customer info, education on the value of working with allergan (sales support, program support, business development support, etc.) 95.1K followers. About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics . Mature consumers value high quality and have personalized . 03 Point Events In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (seeBoxed Warning). Bimatoprost has been reported to cause pigment changes (darkening) to periorbital pigmented tissues and eyelashes. The safety and effectiveness of BOTOXfor unapproved uses have not been established. These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products. Allergan Aesthetics Reaffirms Commitment to Breast Health Advocacy with There have been reports of dry eye associated with BOTOXCosmetic injection in or near the orbicularis oculi muscle. A cookie can be used to enable a site to remember information that you previously input. REVOLVE System is designed to remove localized deposits of excess fat through small incision and subsequently transfer the tissue back to the patient. Filling the device with adipose tissue over the maximum fill volume line can lead to occlusion of the mesh resulting in mesh tear. The CoolTone device is indicated for improvement of abdominal tone, strengthening of the abdominal muscles, and development for firmer abdomen. Injection-Site Hematoma/Bruising Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur, Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled, To minimize the risks of potential complications, this product should only be used by healthcare professionals with appropriate experience and training on facial anatomy and product use in indicated area(s), vasculature, safe injection techniques, and identification and management of potential adverse events, including intravascular complications, The potential risks of soft-tissue injections should be discussed with patients prior to treatment to ensure they are aware of signs and symptoms of complications, The safety and effectiveness for the treatment of anatomic regions other than indicated areas for each product have not been established in controlled clinical studies, The safety for use of these products during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied, The safety for use of JUVDERM VOLUMA XC has been established in patients between 35 and 65 years of age for cheek augmentation and in patients between 22 and 80 years of age for chin augmentation, The safety for use of JUVDERM Ultra Plus XC and JUVDERM Ultra XC in patients under 18 years, and JUVDERM VOLLURE XC and JUVDERM VOLBELLA XC in patients under 22 years, has not been established, As with all transcutaneous procedures, dermal filler implantation carries a risk of infection, Dermal fillers should be used with caution in patients on immunosuppressive therapy, Patients taking medications that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites, Patients who experience skin injury near the site of implantation may be at a higher risk for adverse events, If laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment, or before skin has healed from a procedure prior to treatment, there is a possible risk of eliciting an inflammatory reaction at the injection site, The safety for use of JUVDERM VOLUMA XC injectable gel in patients with very thin skin in the mid-face has not been established, The safety of JUVDERM VOLUMA XC with cannula for cheek augmentation has not been established in patients with Fitzpatrick Skin Types V and VI, JUVDERM VOLUMA XC was not evaluated in subjects with significant skin laxity of the chin, neck, or jaw in the chin augmentation study, The effect of JUVDERM VOLUMA XC injection into the chin on facial hair growth has not been studied, Patients may experience late-onset adverse events with use of these dermal fillers, and late-onset nodules with use of JUVDERM VOLUMA XC, Based on preclinical studies, patients should be limited to 20 mL of any JUVDERM injectable gel per 60 kg (130 lbs) body mass per year.